![Sanjay Rajanikant Mehta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sanjay Rajanikant Mehta
Director/Miembro de la Junta en Zuventus Healthcare Ltd. .
Fortuna: 158 $ al 30/09/2021
Perfil
Sanjay Rajanikant Mehta is currently a Non-Executive Director at Zuventus Healthcare Ltd.
and President-Emerging Markets at Emcure Pharmaceuticals Ltd.
He completed his undergraduate degree at the University of Pune.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. 8.72% | 18/08/2021 | 15 764 028 ( 8.72% ) | 158 $ | 30/09/2021 |
Cargos activos de Sanjay Rajanikant Mehta
Empresas | Cargo | Inicio |
---|---|---|
Zuventus Healthcare Ltd.
![]() Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Director/Miembro de la Junta | 11/05/2011 |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Corporate Officer/Principal | 01/04/1989 |
Formación de Sanjay Rajanikant Mehta.
University of Pune | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Zuventus Healthcare Ltd.
![]() Zuventus Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Zuventus Healthcare Ltd operates as pharmaceutical company. The company was founded in 15th July, 2002 and is headquartered in Mumbai, India. | Health Technology |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Bolsa de valores
- Insiders
- Sanjay Rajanikant Mehta